These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28450850)

  • 1. Cholecystokinin-From Local Gut Hormone to Ubiquitous Messenger.
    Rehfeld JF
    Front Endocrinol (Lausanne); 2017; 8():47. PubMed ID: 28450850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biology of cholecystokinin and gastrin peptides.
    Rehfeld JF; Friis-Hansen L; Goetze JP; Hansen TV
    Curr Top Med Chem; 2007; 7(12):1154-65. PubMed ID: 17584137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical endocrinology and metabolism. Cholecystokinin.
    Rehfeld JF
    Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):569-86. PubMed ID: 15533776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin expression in tumors: biogenetic and diagnostic implications.
    Rehfeld JF
    Future Oncol; 2016 Sep; 12(18):2135-47. PubMed ID: 27306028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the tissue-specific processing of procholecystokinin in the brain and gut--a short review.
    Rehfeld JF; Bungaard JR; Friis-Hansen L; Goetze JP
    J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():73-9. PubMed ID: 15075450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The uncovering and characterization of a CCKoma syndrome in enteropancreatic neuroendocrine tumor patients.
    Rehfeld JF; Federspiel B; Agersnap M; Knigge U; Bardram L
    Scand J Gastroenterol; 2016 Oct; 51(10):1172-8. PubMed ID: 27191542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy.
    Rehfeld JF
    Clin Med Insights Endocrinol Diabetes; 2019; 12():1179551419883608. PubMed ID: 31853211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin peptides as local modulators of thyroidal calcitonin secretion in the dog?
    Laurberg P; Rehfeld JF
    J Endocrinol; 1987 Oct; 115(1):77-82. PubMed ID: 3668449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholecystokinin--gene structure, and molecular forms in tissue and blood.
    Eysselein VE; Reeve JR; Eberlein G
    Z Gastroenterol; 1986 Oct; 24(10):645-59. PubMed ID: 3788230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
    Laverman P; Béhé M; Oyen WJ; Willems PH; Corstens FH; Behr TM; Boerman OC
    Bioconjug Chem; 2004; 15(3):561-8. PubMed ID: 15149184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsulfated cholecystokinins in the small intestine of pigs and rats.
    Agersnap M; Rehfeld JF
    Peptides; 2015 Sep; 71():121-7. PubMed ID: 26206288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
    Behr TM; Béhé MP
    Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsulfated cholecystokinins in cerebral neurons.
    Agersnap M; Zhang MD; Harkany T; Hökfelt T; Rehfeld JF
    Neuropeptides; 2016 Dec; 60():37-44. PubMed ID: 27535680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides.
    Rehfeld JF
    Acta Physiol (Oxf); 2011 Apr; 201(4):405-11. PubMed ID: 21392266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of nonsulfated cholecystokinins.
    Agersnap M; Rehfeld JF
    Scand J Clin Lab Invest; 2014 Aug; 74(5):424-31. PubMed ID: 24734780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin antagonists: pharmacological and therapeutic potential.
    Herranz R
    Med Res Rev; 2003 Sep; 23(5):559-605. PubMed ID: 12789687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsulfated cholecystokinin: An overlooked hormone?
    Rehfeld JF; Agersnap M
    Regul Pept; 2012 Jan; 173(1-3):1-5. PubMed ID: 21985915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prolonged cholecystokinin administration on rat pituitary-adrenocortical axis: role of the CCK receptor subtypes 1 and 2.
    Malendowicz LK; Spinazzi R; Majchrzak M; Nowak M; Nussdorfer GG; Ziolkowska A; Macchi C; Trejter M
    Int J Mol Med; 2003 Dec; 12(6):903-9. PubMed ID: 14612964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procholecystokinin expression and processing in cardiac myocytes.
    Goetze JP; Rehfeld JF
    Peptides; 2019 Jan; 111():71-76. PubMed ID: 29902521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.